Vis enkel innførsel

dc.contributor.authorNordgård, Ståle
dc.contributor.authorAmundsen, Marit Furre
dc.contributor.authorBugten, Vegard
dc.contributor.authorNilsen, Ann Helen
dc.contributor.authorThorstensen, Wenche Moe
dc.contributor.authorMoxness, Mads Henrik Strand
dc.date.accessioned2017-01-24T12:37:59Z
dc.date.available2017-01-24T12:37:59Z
dc.date.created2016-12-14T10:07:45Z
dc.date.issued2016
dc.identifier.issn1472-6815
dc.identifier.urihttp://hdl.handle.net/11250/2428147
dc.description.abstractBackground The goal of this study is to compare quality of life (Qol) and symptoms in 91 patients with a deviated nasal septum preoperatively and postoperatively with a control group of 93 healthy individuals. Methods All patients reported Qol on Sino-Nasal-Outcome-Test-20 (SNOT-20) and symptoms on visual analogue scale (VAS) preoperatively and 6 months after surgery and the results were compared with the controls. Results Mean SNOT-20 score improved from 1.8(SD0.9) preoperatively to 0.9(SD0.8) postoperatively (p < 0.000) but did not reach the same level as the controls 0.4(SD0.5). Septum surgery leads to a significant symptom improvement for all symptoms investigated (p < 0.000) on VAS. The patients reached the same level as the healthy controls in 6 of 11 symptoms (headache, facial pain, sneezing, trouble with rhinosinusitis, cough and snoring) but the patients group had significantly more trouble with nasal blockage (VAS 29 vs 9), change in sense of smell (VAS 12 vs5), nasal discharge (VAS 22 vs 11), oral breathing (VAS 23 vs 13) and reduced general health (VAS 12 vs 5) also postoperatively (p < 0.01). Sub analyses showed that allergic patients reported a VAS score of 36 (SD30) for nasal blockage and 17 (SD22) for facial pressure postoperatively versus 23(SD22) and 6(SD13) in non-allergic patients (p < 0.03 and p < 0.01). Patients with obstructive sleep apnea syndrome (OSAS) reported more trouble with snoring on VAS postoperatively than other patients, 42(SD28) versus 20(SD23) (p < 0.002). Conclusion Septoplasty leads to a highly significant improvement in Qol and symptoms. The patients do not reach the same level of Qol as healthy controls. All symptoms are reported as mild on VAS postoperatively. Allergic patients tend to report more nasal blockage and facial pressure postoperatively than other patients and a focus on medical treatment should be kept also postoperatively. Patients with obstructive sleep apnea report more trouble with snoring postoperatively and alterative treatment options for snoring may be considered in these patients.nb_NO
dc.language.isoengnb_NO
dc.publisherBioMed Centralnb_NO
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.subjectNasal septoplasty – SNOT – Allergic rhinitis – Allergy – Snoring – Obstructive sleep apnea – Chronic rhinosinusitisnb_NO
dc.titleQuality of life and symptoms before and after nasal septoplasty compared with healthy individualsnb_NO
dc.typeJournal articlenb_NO
dc.typePeer reviewednb_NO
dc.source.pagenumber1-7nb_NO
dc.source.volume16nb_NO
dc.source.journalBMC Ear, Nose and Throat Disordersnb_NO
dc.source.issue1nb_NO
dc.identifier.doi10.1186/s12901-016-0031-7
dc.identifier.cristin1412458
dc.description.localcode© 2016 The Author(s). Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.nb_NO
cristin.unitcode194,65,30,0
cristin.unitnameInstitutt for nevromedisin
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode1


Tilhørende fil(er)

Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel

https://creativecommons.org/licenses/by/4.0/
Med mindre annet er angitt, så er denne innførselen lisensiert som https://creativecommons.org/licenses/by/4.0/